Share-Based Compensation | 12. Share-Based Compensation Share-based compensation and the related tax benefit recognized in our condensed consolidated statements of income were as follows (in millions): Three Months Ended Six Months Ended December 31, December 31, 2019 2018 2019 2018 Cost of revenue $ 0.6 $ 0.8 $ 1.3 $ 1.7 Research and development 8.1 8.5 15.6 16.8 Selling, general, and administrative 6.4 6.9 9.4 14.4 Total $ 15.1 $ 16.2 $ 26.3 $ 32.9 Income tax expense/(benefit) on share-based compensation $ (1.8 ) $ 0.3 $ (2.7 ) $ (2.4 ) Included in the preceding table is share-based compensation for our cash-settled phantom stock units, which we granted in October 2019 (see Phantom Stock Units Three Months Ended December 31, 2019 Cost of revenue $ 0.1 Research and development 2.5 Selling, general, and administrative 0.4 Total $ 3.0 Historically, we have issued new shares in connection with our equity-settled share-based compensation plans, however, treasury shares are also available for issuance. Any additional shares repurchased under our common stock repurchase program will be available for issuance under our share-based compensation plans. New Share-Based Compensation Plans On October 29, 2019, our stockholders approved: (i) The 2019 Incentive Plan authorizes our board of directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, cash incentive awards, performance shares, performance units, and other stock-based awards. The number of shares approved by stockholders under the 2019 Incentive Plan was 1,230,000. The 2019 ESPP authorizes the company to provide eligible employees with an opportunity to acquire an equity interest in the company through the purchase of stock at a discount, with an initial authorization of 1,500,000 shares. Effective August 19, 2019, we adopted the 2019 Inducement Equity Plan. 650,000 shares of our common stock have been reserved for issuance under the 2019 Inducement Equity Plan, subject to adjustment for stock dividends, stock splits, or other changes in our common stock or capital structure. The 2019 Inducement Equity Plan is intended to comply with Rule 5635(c)(4) of the Nasdaq Stock Market Listing Rules, which provide an exception to the Nasdaq Stock Market Listing Rules’ on the shareholder approval requirement for the issuance of securities with regards to grants to employees of the Company or its subsidiaries as an inducement material to such individuals entering into employment with the Company or its subsidiaries. An individual is eligible to receive an award under the 2019 Inducement Equity Plan only if he or she was not previously an employee or director of our company (or is returning to work after a bona-fide period of non-employment), and an award under the 2019 Inducement Equity Plan is a material inducement for him or her to accept employment with our company. Stock Options Stock option activity was as follows: Stock Weighted Aggregate Option Average Intrinsic Awards Exercise Value Outstanding Price (in millions) Balance as of June 30, 2019 1,191,929 $ 59.07 Granted — — Exercised (180,278 ) 34.43 Forfeited (99,108 ) 69.18 Balance as of December 31, 2019 912,543 62.84 $ 8.7 Exercisable at December 31, 2019 906,030 62.93 $ 8.6 The aggregate intrinsic value was determined using the closing price of our common stock on December 27, 2019 of $66.89 and excludes the impact of stock options that were not in-the-money. Deferred Stock Units DSU activity was as follows: Aggregate DSU Intrinsic Awards Value Outstanding (in millions) Balance as of June 30, 2019 1,878,853 Granted 600,711 Delivered (780,121 ) Forfeited (225,320 ) Balance as of December 31, 2019 1,474,123 $ 98.6 The aggregate intrinsic value was determined using the closing price of our common stock on December 27, 2019 of $66.89. Of the shares delivered, 184,466 shares valued at $7.4 million were withheld to meet statutory tax withholding requirements. Market Stock Units Our 2019 Incentive Plan and our Amended and Restated 2010 Incentive Compensation Plans provide for the grant of MSU awards to our employees, consultants, and directors, and our 2019 Inducement Equity Plan provides for the grant of MSU awards to certain of our employees. An MSU is a promise to deliver shares of our common stock at a future date based on the achievement of market-based performance requirements in accordance with the terms of the MSU grant agreement. We have granted MSUs to our executive officers and other management members under our Amended and Restated 2010 Incentive Compensation Plan, our 2019 Incentive Plan and our 2019 Inducement Equity Plan, which are designed to vest in three or four tranches with the target quantity for each tranche equal to one-third one-fourth one-year two-year three-year four-year two (100% + ([Synaptics TSR — {SPSISC Index TSR or SOX Index TSR}] x 2)) For MSUs vesting over three years, the payout for the first tranche and the second tranche will not exceed 100% and the payout for the third tranche will be calculated based on the total target quantity for the entire grant multiplied by the payout factor, based on performance for the three-year performance period, less shares issued for the first tranche and the second tranche. For MSUs vesting over four years, the payout for the first tranche, the second tranche and the third tranche will not exceed 100% and the payout for the fourth tranche will be calculated based on the total target quantity for the entire grant multiplied by the payout factor, based on performance for the four-year performance period, less shares issued for the first tranche, the second tranche and the third tranche. Delivery of shares earned, if any, will take place on the dates provided in the applicable MSU grant agreement, assuming the grantee is still an employee, consultant, or director of our company at the end of the applicable performance period. On the delivery date, we withhold shares to cover statutory tax withholding requirements and deliver a net quantity of shares to the employee, consultant, or director after such withholding. Until delivery of shares, the grantee has no rights as a stockholder with respect to any shares underlying the MSU award. MSU activity was as follows: Aggregate MSU Intrinsic Awards Value Outstanding (in millions) Balance as of June 30, 2019 210,732 Granted 328,599 Performance adjustment (58,707 ) Delivered (23,018 ) Forfeited (54,774 ) Balance as of December 31, 2019 402,832 $ 26.9 The aggregate intrinsic value was determined using the closing price of our common stock on December 27, 2019 of $66.89. We value MSUs using the Monte Carlo simulation model on the date of grant and amortize the compensation expense over the three- or four-year performance and service period on a straight-line basis. The unrecognized share-based compensation cost of our outstanding MSUs was approximately $19.4 million as of December 31, 2019, which will be recognized over a weighted average period of approximately 1.8 years. Performance Stock Units Our 2019 Incentive Plan and our Amended and Restated 2010 Incentive Compensation Plan provide for the grant of PSU awards to our employees, consultants, and directors. A PSU is a promise to deliver shares of our common stock at a future date based on the achievement of performance-based requirements in accordance with the terms of the PSU grant agreement. We have granted PSUs to our executive officers and other management members under our Amended and Restated 2010 Incentive Compensation Plan, our 2019 Incentive Plan and our 2019 Inducement Equity Plan, which are designed to vest in three tranches with the target quantity for each tranche equal to one-third Delivery of shares earned, if any, will take place on the dates provided in the applicable PSU grant agreement, assuming the grantee is still an employee, consultant, or director of our company at the end of the applicable service period. On the delivery date, we withhold shares to cover statutory tax withholding requirements and deliver a net quantity of shares to the employee, consultant, or director after such withholding. Until delivery of shares, the grantee has no rights as a stockholder with respect to any shares underlying the PSU award. PSU activity was as follows: Aggregate PSU Intrinsic Awards Value Outstanding (in millions) Balance as of June 30, 2019 192,618 Awarded 328,023 Performance adjustment (10,242 ) Released (61,668 ) Forfeited (70,441 ) Balance as of December 31, 2019 378,290 $ 25.3 The aggregate intrinsic value was determined using the closing price of our common stock on December 27, 2019 of $66.89. We value PSUs using the aggregate intrinsic value on the date of grant adjusted for estimated performance achievement during the performance period and amortize the compensation expense over the three-year Phantom Stock Units The 2019 Incentive Plan authorizes the grant of phantom stock units to non-employee directors, officers and employees. We initially granted phantom stock units in October 2019. Phantom stock units are cash-settled and entitle the recipient to receive a cash payment equal to the value of a single share for each unit based on the average closing share price of our stock over the thirty calendar days prior to the vesting date. Grants of phantom stock units vest over three years, with an annual vesting date of October 31 each year subsequent to the grant date. We recognize compensation expense for phantom stock units on a straight-line basis for each tranche of each award based on the average closing price of our common stock over the thirty calendar days ended prior to each balance sheet date. The outstanding phantom stock units had a fair value of $62.02 per unit at December 31, 2019 and our accrued liability for such units was $3.0 million. Phantom stock activity was as follows: Aggregate Phantom Intrinsic Stock Units Value Outstanding (in millions) Granted 953,305 Forfeited (45,496 ) Balance as of December 31, 2019 907,809 $ 60.7 The aggregate intrinsic value was determined using the closing price of our common stock on December 27, 2019 of $66.89. The unrecognized share-based compensation cost of our outstanding phantom stock units was approximately $53.3 million as of December 31, 2019, which will be recognized over a weighted average period of approximately 2.8 years. Employee Stock Purchase Plan Shares purchased, weighted average purchase price, cash received, and the aggregate intrinsic value for employee stock purchase plan purchases during the six months ended December 31, 2019 were as follows (in millions, except for shares purchased and weighted average price): Shares purchased 275,473 Weighted average purchase price $ 25.86 Cash received $ 7.1 Aggregate intrinsic value $ 9.5 |